20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1].
[1]. Parlati F, et, al. Novel substrate for rpn 11 enzymatic activity. WO2006128196A2.
















